Charles River Labs Downgraded at Argus on Cautious Biotech Spending
These Nike Analysts Are No Longer Bullish; Here Are Top 5 Downgrades For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag
Demystifying Charles River: Insights From 4 Analyst Reviews
During the last three months, 4 analysts shared their evaluations of Charles River (NYSE:CRL), revealing diverse outlooks from bullish to bearish.The table below offers a condensed view of their recen
Argus Research Downgrades Charles River(CRL.US) to Hold Rating
Argus Research analyst David Toung downgrades $Charles River(CRL.US)$ to a hold rating.According to TipRanks data, the analyst has a success rate of 62.0% and a total average return of 9.3% over the p
Charles River Labs Cut to Hold From Buy by Argus Research
Charles River Labs Cut to Hold From Buy by Argus Research
Express News | Argus Research Downgrades Charles River to Hold
Express News | Charles River Labs : Barclays Initiates Coverage With Equal-Weight Rating and Target Price $230
Barclays Maintains Charles River(CRL.US) With Hold Rating, Maintains Target Price $230
Barclays analyst Luke Sergott maintains $Charles River(CRL.US)$ with a hold rating, and maintains the target price at $230.According to TipRanks data, the analyst has a success rate of 39.9% and a tot
Charles River's (CRL) RMS Growth Aids Amid FX Headwind
Barclays Initiates Charles River(CRL.US) With Hold Rating, Announces Target Price $230
Barclays analyst Luke Sergott initiates coverage on $Charles River(CRL.US)$ with a hold rating, and sets the target price at $230.According to TipRanks data, the analyst has a success rate of 40.5% an
Express News | Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration With Gates Institute at University of Colorado Anschutz Medical Campus
Is Weakness In Charles River Laboratories International, Inc. (NYSE:CRL) Stock A Sign That The Market Could Be Wrong Given Its Strong Financial Prospects?
Charles River Laboratories International (NYSE:CRL) has had a rough three months with its share price down 20%. However, a closer look at its sound financials might cause you to think again. Given t
Charles River Associates (CRA) to Present at Noble Capital Markets Virtual Conference
Charles River Associates (CRA) Strengthens Its Energy Practice
Charles River Associates (NASDAQ:CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that Christine Oumansour has joined the company as a Vice President in the
Charles River and Captain T Cell Sign Vector Production Agreement
Charles River Laboratories, Captain T Cell Enter Manufacturing Deal
Charles River Laboratories (CRL) and Captain T Cell said Monday that they have entered into a plasmid DNA and retrovirus vector production program deal. Captain T Cell will use plasmid and viral vecto
Express News | Charles River Laboratories And Captain T Cell Announce Plasmid DNA And Retrovirus Vector Production Agreement; Captain T Cell To Utilize Charles River's CGT Accelerator Program For Phase I Clinical Trial Of TCR-T Cell Therapy For Solid Tumors
Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy
Leveraging CGT CDMO expertise to support T-cell immunotherapy clinical trial Charles River Laboratories International, Inc. (NYSE:CRL) and Captain T Cell, a spinoff from the renowned Max Delbrück Center Berlin,
Express News | Charles River Laboratories International Inc : Baird Raises Target Price to $271 From $270
Charles River and Octaura Launch Two-Way Interface for Simplified Syndicated Loan Trading